6th Apr 2009 13:25
RNS Number : 2055Q
AGI Therapeutics plc
06 April 2009
AGI Therapeutics plc ('AGI')
Holding in Company
AGI was notified on 6 April 2009 that Irish Life Investment Managers had increased its shareholding to 5,115,767 Ordinary Shares representing 7.59% of AGI's Issued Share Capital.
Contact Information
AGI Therapeutics
David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Potentially Ai